Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DASATINIB”

313 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 313 results

Testing effectiveness (Phase 2)Ended earlyNCT02954523
What this trial is testing

Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations

Who this might be right for
EGFR Gene MutationNonsmall Cell Lung Cancer
Chul Kim 10
Testing effectiveness (Phase 2)Looking for participantsNCT05527418
What this trial is testing

Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection

Who this might be right for
Recent HIV-1 Infection
Eva Bonfill 24
Testing effectiveness (Phase 2)Ended earlyNCT00564876
What this trial is testing

Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Duke University 2
Post-approval studies (Phase 4)UnknownNCT03216070
What this trial is testing

Low-dose Dasatinib as First-line Treatment for Chronic Myeloid Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
Hospital Universitario Dr. Jose E. Gonzalez 12
Not applicableEnded earlyNCT01169753
What this trial is testing

Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients

Who this might be right for
Chronic Myeloid Leukemia
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT05007873
What this trial is testing

ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
Chronic Phase Chronic Myelogenous LeukemiaPhiladelphia Chromosome PositiveBCR-ABL1 Positive Chronic Myelogenous Leukemia+1 more
M.D. Anderson Cancer Center 70
Testing effectiveness (Phase 2)Study completedNCT00410813
What this trial is testing

S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone

Who this might be right for
Breast CancerMetastatic Cancer
SWOG Cancer Research Network 85
Early research (Phase 1)Ended earlyNCT00598091
What this trial is testing

A Phase I/Expansion Study of Dasatinib

Who this might be right for
Refractory Solid TumorsPancreatic Adenocarcinoma
Duke University 30
Early research (Phase 1)Study completedNCT00662636
What this trial is testing

Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Mayo Clinic 27
Early research (Phase 1)Active Not RecruitingNCT02389309
What this trial is testing

Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Brain NeoplasmRecurrent Malignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT01238211
What this trial is testing

Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11+5 more
National Cancer Institute (NCI) 61
Testing effectiveness (Phase 2)Study completedNCT03625388
What this trial is testing

Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
Hikma Pharmaceuticals LLC 56
Testing effectiveness (Phase 2)Study completedNCT01725204
What this trial is testing

Safety and Efficacy of Pegylated IFN-alpha 2B Added to Dasatinib in Newly Diagnosed Chronic Phase Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Chronic-Phase
Norwegian University of Science and Technology 40
Testing effectiveness (Phase 2)Study completedNCT00568750
What this trial is testing

Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumor
Swiss Cancer Institute 47
Early research (Phase 1)Study completedNCT02081378
What this trial is testing

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

Who this might be right for
Chronic Myelogenous LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 326
Not applicableStudy completedNCT01464047
What this trial is testing

Korean Post-marketing Surveillance for Sprycel®

Who this might be right for
Leukemia, Myelomonocytic, ChronicLeukemia-Lymphoma
Bristol-Myers Squibb 670
Testing effectiveness (Phase 2)WithdrawnNCT01410708
What this trial is testing

TORI 104 Pre-Surgical Dasatinib

Who this might be right for
Breast Cancer
AHS Cancer Control Alberta
Not applicableUnknownNCT01464411
What this trial is testing

Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelogenous Leukemia, Chronic, Chronic Phase
Kanto CML Study Group 40
Testing effectiveness (Phase 2)Looking for participantsNCT01746836
What this trial is testing

Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib

Who this might be right for
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositivePhiladelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00570401
What this trial is testing

Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 22
Load More Results
50